Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2023)
Nautilus Biotechnology's (NAUT) quarterly Other Non Operating Income came in at -$14000.0 in Q2 2023, down 300.0% year-on-year from $7000.0 in Q2 2022, and up 89.39% quarter-over-quarter from -$132000.0 in Q3 2022.
Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2023) Analysis & Trends
Nautilus Biotechnology has disclosed Other Non Operating Income across 3 years of filings, most recently posting -$14000.0 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Nautilus Biotechnology | 298.22 Mn | 202.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -14,000.00 |
| Sep 30, 2022 | -132,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Sep 30, 2021 | -72,000.00 |